BMS 387032,
BMS-387032,
BMS387032,
N-(5-(((5-(1,1-dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-piperidinecarboxamide,
SNS 032,
SNS-032,
345627-80-7,
SNS-032,
BMS-387032,
SNS 032,
BMS 387032,
N-[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]piperidine-4-carboxamide,
SNS-032 (BMS-387032),
N-(5-(((5-(tert-Butyl)oxazol-2-yl)methyl)thio)thiazol-2-yl)piperidine-4-carboxamide,
N-(5-{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl}-1,3-thiazol-2-yl)piperidine-4-carboxamide,
UNII-9979I93686,
N-(5-(((5-(1,1-Dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-piperidinecarboxamide,
CHEMBL296468,
SNS032,
C17H24N4O2S2,
BMS387032,
N-[5-[[[5-(1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4-piperidinecarboxamide,
AK113734,
N-(5-((5-tert-butyloxazol-2-yl)methylthio)thiazol-2-yl)piperidine-4-carboxamide,
9979I93686,
4-Piperidinecarboxamide, N-(5-(((5-(1,1-dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-,
BMS-387072,
OUSFTKFNBAZUKL-UHFFFAOYSA-N,
n-(5-((5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl)-1,3-thiazol-2-yl)piperidine-4-carboxamide,
Kinome_3820,
PubChem16670,
Tube004,
AC1MHGD4,
MLS006011029,
SCHEMBL187401,
BDBM5931,
GTPL5670,
CHEBI:91399,
cid_3025986,
CTK4H2598,
DTXSID50188100,
EX-A054,
BCPP000066,
HMS3654G10,
ACT06674,
BCP01951,
ZINC3816409,
ABP000845,
MFCD09833875,
s1145,
AKOS015898717,
AN-3519,
API0007075,
RL03281,
SB16651,
BMS-3870032,
KS-0000063E,
N-(5-(((5-(1,1-Dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-peridinecarboxamide,
NCGC00263167-01,
NCGC00263167-02,
4CA-1169,
AC-26846,
AJ-45713,
AS-35116,
BC224785,
HY-10008,
SC-84716,
SMR004702824,
SNS-032(BMS-387032),
SNS-032, BMS-387032,
AB0033696,
AB1008461,
AX8165410,
LS-186036,
SNS-032 - BMS-387032,
A6078,
FT-0674612,
SW219478-1,
X7382,
A20554,
W-5410,
627B807,
I09-1579,
J-019645,
J-523350,
BRD-K43389698-001-01-6,
SNS-032, 345627-80-7,
SNS-032(BMS387032)/SNS032,BMS-387032,
N-(5-((5-tert-butyloxazol-2-yl)methylthio)thiazol-2-yl)piperidine-4-carboxamide;SNS-032,
N-[5-[(5-tert-butyloxazol-2-yl)methylsulfanyl]thiazol-2-yl]piperidine-4-carboxamide,
4-Piperidinecarboxamide,N-[5-[[[5-(1,1-dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-,
56H,
N-[5-[(5-tert-Butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]piperidine-4-carboxamide; SNS-032,
n-[5-[[[5-(1,1-dimethylethyl)-2-oxazolyl]methyl]-thio]-2-thiazolyl]-4-piperidinecarboxamide,
SNS-032|||N-[5-[(5-tert-Butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]piperidine-4-carboxamide,
D0S5RC,
cc-229,
C17-H24-N4-O2-S2,
CID3025986,
CS-0021,
SNS-032BMS-3870032,
(2R,3R)-2,3-dihydroxybutanedioic acid,
tert-Butyl 6-Bromopyridin-2-ylcarbamate,
BMS-387032, SNS-032,
A1980,
A10850,
SNS-032, 98.5%, a selective CDK2 inhibitor - 25MG 25mg,
N-[5-[ methylsulfanyl]-1,3-thiazol-2-yl]piperidine-4-carboxamide,
345627-92-1,
345627-90-9,
N-[5-[[[5-(1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4-piperidinecarboxamide L-tartaric acid salt (2:1),